ADENOSINE RECEPTOR ANTAGONISTS POTENTIATE DOPAMINE RECEPTOR AGONIST-INDUCED ROTATIONAL BEHAVIOR IN 6-HYDROXYDOPAMINE-LESIONED RATS

被引：83
|
作者：
JIANG, H
JACKSONLEWIS, V
MUTHANE, U
DOLLISON, A
FERREIRA, M
ESPINOSA, A
PARSONS, B
PRZEDBORSKI, S
机构：
[1] COLUMBIA UNIV,DEPT NEUROL,BLACK BLDG,ROOM 307,650 W 168TH ST,NEW YORK,NY 10032
[2] COLUMBIA UNIV,DEPT PSYCHIAT,NEW YORK,NY 10032
来源：
BRAIN RESEARCH | 1993年 / 613卷 / 02期
关键词：
ADENOSINE; DOPAMINE; PARKINSONS DISEASE; ROTATIONAL BEHAVIOR; 6-HYDROXYDOPAMINE;
D O I：
10.1016/0006-8993(93)90925-D
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Adenosine receptor antagonists, DMPX, PACPX and theophylline, produce contralateral rotations in unilateral 6-hydroxydopamine-lesioned rats. DMPX and theophylline markedly increase rotations produced by bromocriptine (a dopamine D2 receptor agonist) and/or SKF38393A (a dopamine D1 receptor agonist). All of these effects are inhibited by CGS21680C (an adenosine A2 receptor agonist). These findings suggest synergistic interactions among D1, D2 and A2 receptors that may be relevant to the treatment of Parkinson's disease.
引用
收藏
页码：347 / 351
页数：5
相关论文
共 50 条
  • [21] Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA
    Tomiyama, M
    Kimura, T
    Maeda, T
    Tanaka, H
    Kannari, K
    Baba, M
    SYNAPSE, 2004, 52 (03) : 218 - 222
  • [22] Prior Treatment (Priming) with Caffeine Sensitizes D2-Dopamine-Mediated Contralateral Rotational Behavior in 6-Hydroxydopamine-Lesioned Rats
    Pollack, Alexia E.
    Dimitrov, Kroum D.
    Drake, Jonathan D.
    PHARMACOLOGY, 2010, 86 (02) : 73 - 78
  • [23] 5-HT2C receptor antagonists enhance the behavioural response to dopamine D1 receptor agonists in the 6-hydroxydopamine-lesioned rat
    Fox, SH
    Brotchie, JM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 398 (01) : 59 - 64
  • [24] Modulation in expression of neurokinin receptor NK1 in the striaturn of 6-hydroxydopamine-lesioned rats
    Chan, W. S.
    Chen, L. W.
    Chan, Y. S.
    Yung, K. K. L.
    NEUROSIGNALS, 2006, 15 (03) : 120 - 120
  • [25] Chronic administration of the histamine H3 receptor agonist immepip decreases l-Dopa-induced dyskinesias in 6-hydroxydopamine-lesioned rats
    Avila-Luna, Alberto
    Rios, Camilo
    Galvez-Rosas, Arturo
    Montes, Sergio
    Arias-Montano, Jose-Antonio
    Bueno-Nava, Antonio
    PSYCHOPHARMACOLOGY, 2019, 236 (06) : 1937 - 1948
  • [26] Chronic administration of the histamine H3 receptor agonist immepip decreases l-Dopa-induced dyskinesias in 6-hydroxydopamine-lesioned rats
    Alberto Avila-Luna
    Camilo Ríos
    Arturo Gálvez-Rosas
    Sergio Montes
    José-Antonio Arias-Montaño
    Antonio Bueno-Nava
    Psychopharmacology, 2019, 236 : 1937 - 1948
  • [27] Contribution of D1 receptor stimulation to the development of levodopa-induced dyskinesias in 6-hydroxydopamine-lesioned rats
    Tomiyama, Masahiko
    Kimura, Tamaki
    Arai, Akira
    Kannari, Kazuya
    Baba, Masayuki
    Matsunaga, Muneo
    PARKINSONISM & RELATED DISORDERS, 2006, 12 : S89 - S89
  • [28] In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats
    Sarre, S
    Yuan, H
    Jonkers, N
    Van Hemelrijck, A
    Ebinger, G
    Michotte, Y
    JOURNAL OF NEUROCHEMISTRY, 2004, 90 (01) : 29 - 39
  • [29] Dopamine agonist-induced yawning in rats: A dopamine D3 receptor-mediated behavior
    Collins, GT
    Witkin, JM
    Newman, AH
    Svensson, KA
    Grundt, P
    Cao, JJ
    Woods, JH
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (01): : 310 - 319
  • [30] Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia
    Maranis, Sotirios
    Stamatis, Dimitrios
    Tsironis, Christos
    Konitsiotis, Spiridon
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 683 (1-3) : 71 - 77
12345